Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-7 of 7 for your search:
Drug:
HspE7
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I/II Study of SGN-00101 in HIV-Positive Patients With High-Grade Anal Squamous Intraepithelial Neoplasia
Phase:
Phase II, Phase I
Type:
Prevention
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
AMC-035
, NCT00052897
2.
Phase II Randomized Study of SGN-00101 in Patients With Grade III Cervical Intraepithelial Neoplasia
Phase:
Phase II
Type:
Prevention
Status:
Completed
Age:
17 and over
Sponsor:
NCI
Protocol IDs:
GOG-0197
, NCT00054041
3.
Phase II Randomized Study of SGN-00101 in Patients With Grade II or III Cervical Intraepithelial Neoplasia
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
BWH-000-P-CONS01
, NCI-3074, NCT00060099, 3074
4.
Phase II Study of SGN-00101 Immunotherapy in Patients With Grade III Cervical Intraepithelial Neoplasia
Phase:
Phase II
Type:
Prevention
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
AECM-0309225
, NCI-5850, NCT00075569, 5850
5.
A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis
Phase:
Phase II
Type:
Prevention, Treatment
Status:
Completed
Age:
2 to 18
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
Stressgen SGN-00101-0005
, SGN-00101-0005, NCT00038714
6.
Phase II Randomized Study of SGN-00101 Vaccine in Human Papillomavirus-16-Positive Patients With Atypical Squamous Cells of Undetermined Significance or Low-Grade Squamous Intraepithelial Lesions of the Cervix
Phase:
Phase II
Type:
Prevention
Status:
Closed
Age:
18 to 50
Sponsor:
NCI
Protocol IDs:
UCIRVINE-02-55
, UCIRVINE-2002-2758, NCT00091130
7.
Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia
Phase:
Phase I
Type:
Prevention
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
HspE7-00101-0601
, NCT00493545
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute